Iocyte Faraday STEMI drug

The purpose of this study is to evaluate the efficacy and safety of the study drug vs placebo in subjects with an anterior ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI).
Contact phone
Sparrow Clinical Research Institute | 517.364.5760
Contact email
Principal investigator
Dr. Mohammed Qintar, MD
Trial Category
Heart & Vascular
Trial SubCategory
Heart Failure